These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 19342157

  • 1. PI3K/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF, in human cancer cell lines.
    Shafee N, Kaluz S, Ru N, Stanbridge EJ.
    Cancer Lett; 2009 Sep 08; 282(1):109-15. PubMed ID: 19342157
    [Abstract] [Full Text] [Related]

  • 2. Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3'-kinase.
    Kaluz S, Kaluzová M, Chrastina A, Olive PL, Pastoreková S, Pastorek J, Lerman MI, Stanbridge EJ.
    Cancer Res; 2002 Aug 01; 62(15):4469-77. PubMed ID: 12154057
    [Abstract] [Full Text] [Related]

  • 3. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo.
    Said HM, Hagemann C, Staab A, Stojic J, Kühnel S, Vince GH, Flentje M, Roosen K, Vordermark D.
    Radiother Oncol; 2007 Jun 01; 83(3):398-405. PubMed ID: 17524506
    [Abstract] [Full Text] [Related]

  • 4. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
    Lim CS, Kiriakidis S, Paleolog EM, Davies AH.
    J Vasc Surg; 2012 May 01; 55(5):1427-39. PubMed ID: 22277691
    [Abstract] [Full Text] [Related]

  • 5. Src induces expression of carbonic anhydrase IX via hypoxia-inducible factor 1.
    Takacova M, Holotnakova T, Barathova M, Pastorekova S, Kopacek J, Pastorek J.
    Oncol Rep; 2010 Mar 01; 23(3):869-74. PubMed ID: 20127031
    [Abstract] [Full Text] [Related]

  • 6. DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX.
    Kaluzová M, Kaluz S, Lerman MI, Stanbridge EJ.
    Mol Cell Biol; 2004 Jul 01; 24(13):5757-66. PubMed ID: 15199132
    [Abstract] [Full Text] [Related]

  • 7. Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?
    Kaluz S, Kaluzová M, Liao SY, Lerman M, Stanbridge EJ.
    Biochim Biophys Acta; 2009 Apr 01; 1795(2):162-72. PubMed ID: 19344680
    [Abstract] [Full Text] [Related]

  • 8. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
    Blancher C, Moore JW, Robertson N, Harris AL.
    Cancer Res; 2001 Oct 01; 61(19):7349-55. PubMed ID: 11585776
    [Abstract] [Full Text] [Related]

  • 9. MAPK pathway contributes to density- and hypoxia-induced expression of the tumor-associated carbonic anhydrase IX.
    Kopacek J, Barathova M, Dequiedt F, Sepelakova J, Kettmann R, Pastorek J, Pastorekova S.
    Biochim Biophys Acta; 2005 May 25; 1729(1):41-9. PubMed ID: 15833446
    [Abstract] [Full Text] [Related]

  • 10. Extracellular acidosis elevates carbonic anhydrase IX in human glioblastoma cells via transcriptional modulation that does not depend on hypoxia.
    Ihnatko R, Kubes M, Takacova M, Sedlakova O, Sedlak J, Pastorek J, Kopacek J, Pastorekova S.
    Int J Oncol; 2006 Oct 25; 29(4):1025-33. PubMed ID: 16964400
    [Abstract] [Full Text] [Related]

  • 11. Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis.
    Tanaka H, Yamamoto M, Hashimoto N, Miyakoshi M, Tamakawa S, Yoshie M, Tokusashi Y, Yokoyama K, Yaginuma Y, Ogawa K.
    Cancer Res; 2006 Dec 01; 66(23):11263-70. PubMed ID: 17145871
    [Abstract] [Full Text] [Related]

  • 12. Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells.
    Duyndam MC, van Berkel MP, Dorsman JC, Rockx DA, Pinedo HM, Boven E.
    Biochem Pharmacol; 2007 Jul 15; 74(2):191-201. PubMed ID: 17498666
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours.
    Dungwa JV, Hunt LP, Ramani P.
    BMC Cancer; 2011 Sep 12; 11():390. PubMed ID: 21910893
    [Abstract] [Full Text] [Related]

  • 14. Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX.
    Chen CL, Chu JS, Su WC, Huang SC, Lee WY.
    Virchows Arch; 2010 Jul 12; 457(1):53-61. PubMed ID: 20526721
    [Abstract] [Full Text] [Related]

  • 15. Celecoxib Down-Regulates the Hypoxia-Induced Expression of HIF-1α and VEGF Through the PI3K/AKT Pathway in Retinal Pigment Epithelial Cells.
    Sun YZ, Cai N, Liu NN.
    Cell Physiol Biochem; 2017 Jul 12; 44(4):1640-1650. PubMed ID: 29216640
    [Abstract] [Full Text] [Related]

  • 16. Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours.
    Jubb AM, Pham TQ, Hanby AM, Frantz GD, Peale FV, Wu TD, Koeppen HW, Hillan KJ.
    J Clin Pathol; 2004 May 12; 57(5):504-12. PubMed ID: 15113858
    [Abstract] [Full Text] [Related]

  • 17. Expression of hypoxia-inducible factor 1 alpha in thyroid carcinomas.
    Burrows N, Resch J, Cowen RL, von Wasielewski R, Hoang-Vu C, West CM, Williams KJ, Brabant G.
    Endocr Relat Cancer; 2010 Mar 12; 17(1):61-72. PubMed ID: 19808899
    [Abstract] [Full Text] [Related]

  • 18. Activation of hypoxia-induced transcription in normoxia.
    Hägg M, Wennström S.
    Exp Cell Res; 2005 May 15; 306(1):180-91. PubMed ID: 15878343
    [Abstract] [Full Text] [Related]

  • 19. Regulation of hypoxia-inducible genes by ETS1 transcription factor.
    Salnikow K, Aprelikova O, Ivanov S, Tackett S, Kaczmarek M, Karaczyn A, Yee H, Kasprzak KS, Niederhuber J.
    Carcinogenesis; 2008 Aug 15; 29(8):1493-9. PubMed ID: 18381358
    [Abstract] [Full Text] [Related]

  • 20. Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α.
    Kim YJ, Lee HJ, Kim TM, Eisinger-Mathason TS, Zhang AY, Schmidt B, Karl DL, Nakazawa MS, Park PJ, Simon MC, Yoon SS.
    Int J Cancer; 2013 Jan 01; 132(1):29-41. PubMed ID: 22684860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.